セクター比較に戻る
医薬品79社のうち、ROEの高い40社を表示。
医薬品
同業他社の主要KPIを一覧比較
企業別KPIヒートマップ
ROE・営業利益率・成長率・自己資本比率・PBRROE中央値推移（P25/P75バンド）
5年間の業種統計帯域はP25〜P75の四分位範囲。中央値は太線。企業数3社未満の年は除外。
KPI比較テーブル
79社株価データは 2026年9月17日時点 のものです（4営業日前）。最新の市場価格とは異なります。
| コード | 企業名 | 市場 | 売上高 | ROE | ROIC | 営利率 | 純利率 | 粗利率 | 自己資本比率 | 売上YoY | FCF率 | PER | PBR | 配当利回 | 流動比率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 業界平均（中央値） | - | 1.2 | -0.3 | 7.2 | 2.2 | 56.7 | 69.9 | 3.9 | 1.5 | 17.0 | 1.8 | 3.0 | 424.6 | ||
| 4506 | 住友ファーマ | prime | 453294M | 46.3 | 21.8 | 23.7 | 23.6 | 56.7 | 36.4 | 13.7 | 20.8 | 5.9 | 2.2 | - | 102.9 |
| 197A | タウンズ | standard | 14369M | 29.8 | 9.7 | 29.2 | 38.2 | 61.4 | 43.5 | -22.9 | -62.6 | 9.9 | 2.9 | 5.4 | 126.3 |
| 4519 | 中外製薬 | prime | 1257941M | 22.1 | 21.5 | 47.6 | 34.5 | 71.1 | 82.1 | 7.5 | 14.7 | 25.3 | 5.4 | 4.1 | 423.5 |
| 4570 | 免疫生物研究所 | growth | 1005M | 19.6 | 14.8 | 28.0 | 32.7 | 70.4 | 85.5 | 3.7 | 18.4 | 32.4 | 5.8 | 0.5 | 568.3 |
| 4595 | ミズホメディー | standard | 11260M | 19.0 | 17.7 | 41.3 | 30.4 | 69.4 | 83.5 | -1.5 | -47.3 | 9.7 | 1.8 | 5.8 | 736.1 |
| 4503 | アステラス製薬 | prime | 2139245M | 17.4 | 13.4 | 17.9 | 13.6 | 80.9 | 51.3 | 11.9 | 23.1 | 14.5 | 2.3 | 3.3 | 116.7 |
| 4568 | 第一三共 | prime | 2123045M | 16.9 | 14.5 | 12.2 | 13.2 | 68.5 | 42.1 | 12.6 | -3.3 | 19.4 | 3.2 | 2.7 | 250.3 |
| 4507 | 塩野義製薬 | prime | 499677M | 13.5 | 6.1 | 33.4 | 41.2 | 83.5 | 65.4 | 14.0 | -58.6 | 12.4 | 1.5 | 2.4 | 158.4 |
| 4536 | 参天製薬 | prime | 291624M | 12.8 | 12.7 | 16.4 | 12.9 | 58.2 | 70.2 | -2.8 | 10.5 | 15.5 | 1.9 | 2.2 | 260.3 |
| 4578 | 大塚ホールディングス | prime | 2468892M | 12.6 | 12.7 | 19.4 | 14.8 | 71.7 | 72.3 | 6.0 | 9.8 | 16.4 | 2.0 | 1.2 | 216.5 |
| 4527 | ロート製薬 | prime | 343725M | 12.2 | 9.8 | 12.0 | 10.0 | 56.1 | 62.1 | 11.4 | 5.2 | 18.8 | 2.1 | 1.6 | 203.9 |
| 4574 | 大幸薬品 | prime | 6397M | 11.2 | 4.6 | 7.2 | 14.4 | 54.4 | 69.4 | 1.7 | 14.9 | 14.0 | 1.5 | 1.3 | 336.1 |
| 4516 | 日本新薬 | prime | 170771M | 11.0 | 9.9 | 20.8 | 17.4 | 66.4 | 84.2 | 6.6 | 17.1 | 7.9 | 0.8 | 3.6 | 434.8 |
| 4540 | ツムラ | prime | 192615M | 9.0 | 6.3 | 18.3 | 15.7 | 47.5 | 54.3 | 6.4 | -13.3 | 10.3 | 0.9 | 3.8 | 419.4 |
| 4528 | 小野薬品工業 | prime | 515785M | 8.5 | 7.4 | 17.9 | 13.6 | 72.5 | 76.9 | 5.9 | 18.8 | 16.1 | 1.3 | 3.3 | 286.2 |
| 4559 | ゼリア新薬工業 | prime | 89159M | 8.5 | 6.4 | 13.9 | 9.4 | 73.1 | 60.3 | 2.1 | 8.1 | 10.6 | 0.8 | 2.4 | 148.4 |
| 4549 | 栄研化学 | prime | 41899M | 8.5 | 4.8 | 7.0 | 8.8 | 38.6 | 70.1 | 3.4 | 1.5 | 21.0 | 1.8 | 2.5 | 218.9 |
| 4886 | あすか製薬ホールディングス | prime | 71127M | 8.0 | 5.4 | 8.2 | 7.9 | 48.0 | 62.6 | 10.9 | 0.8 | 11.2 | 0.9 | 2.8 | 275.6 |
| 4151 | 協和キリン | prime | 496826M | 7.7 | 1.7 | - | 13.5 | 74.2 | 80.6 | 0.3 | 1.5 | 17.7 | 1.3 | 2.7 | 272.5 |
| 4554 | 富士製薬工業 | prime | 51677M | 6.5 | 4.7 | 9.7 | 5.8 | 40.2 | 50.2 | 12.0 | 3.1 | 15.2 | 1.0 | 2.4 | 154.6 |
| 4885 | 室町ケミカル | standard | 7841M | 6.5 | 8.5 | 9.5 | 2.1 | 30.1 | 40.6 | 17.9 | 7.3 | 21.3 | 1.3 | 3.0 | 200.7 |
| 4547 | キッセイ薬品工業 | prime | 97406M | 6.3 | -0.8 | -3.0 | 14.3 | 47.0 | 83.7 | 10.3 | 16.4 | 12.1 | 0.7 | 4.0 | 530.1 |
| 4577 | ダイト | prime | 50650M | 6.0 | 4.7 | 7.2 | 6.2 | 19.5 | 72.2 | 0.0 | 9.8 | 12.3 | 0.7 | 3.0 | 261.7 |
| 4887 | サワイグループホールディングス | prime | 201676M | 5.9 | 4.7 | 7.9 | 5.2 | 29.2 | 49.6 | 6.7 | -7.7 | 18.4 | 1.1 | 3.3 | 247.5 |
| 4538 | 扶桑薬品工業 | prime | 62307M | 5.9 | 3.8 | 4.2 | 3.2 | 25.7 | 38.8 | 2.9 | -12.4 | 9.6 | 0.6 | 4.0 | 110.9 |
| 4534 | 持田製薬 | prime | 116951M | 5.8 | 4.5 | 8.7 | 6.8 | 48.1 | 76.8 | 11.2 | -20.7 | 14.9 | 0.8 | 2.4 | 429.2 |
| 4524 | 森下仁丹 | standard | 12688M | 5.0 | 3.8 | 5.5 | 4.9 | 48.0 | 69.7 | -0.6 | -0.6 | 14.6 | 0.7 | 2.9 | 301.6 |
| 4552 | JCRファーマ | prime | 40319M | 4.6 | 0.5 | 1.4 | 5.5 | 74.9 | 42.9 | 21.9 | -31.3 | 28.8 | 1.3 | 3.9 | 116.5 |
| 4523 | エーザイ | prime | 825378M | 4.4 | 3.3 | 5.3 | 4.9 | 76.8 | 62.0 | 4.6 | 2.4 | 36.2 | 1.6 | 3.2 | 223.8 |
| 4579 | ラクオリア創薬 | growth | 3980M | 4.4 | 3.4 | 12.2 | 6.9 | - | 65.1 | 28.1 | -5.8 | 50.5 | 2.1 | - | 445.7 |
| 4558 | 中京医薬品 | standard | 6569M | 3.3 | 1.9 | 1.9 | 1.3 | 56.6 | 48.8 | 4.2 | -3.1 | 25.5 | 0.8 | 2.5 | 168.9 |
| 4553 | 東和薬品 | prime | 273710M | 3.0 | 3.0 | 8.4 | 1.9 | 36.2 | 37.5 | 5.4 | 1.7 | 35.5 | 1.0 | 2.1 | 276.0 |
| 219A | Heartseed | growth | 3026M | 2.8 | 2.5 | 9.0 | 6.3 | - | 93.7 | - | 38.1 | 291.5 | 7.8 | - | 2230.1 |
| 4569 | 杏林製薬 | prime | 126257M | 2.5 | 1.6 | 2.8 | 2.7 | 40.9 | 72.9 | -2.9 | 3.8 | 19.1 | 0.5 | 5.0 | 460.2 |
| 4548 | 生化学工業 | prime | 36645M | 2.0 | -0.7 | -1.8 | 4.0 | 43.6 | 87.2 | -6.9 | -13.2 | 25.4 | 0.5 | 4.4 | 534.3 |
| 4512 | わかもと製薬 | standard | 9907M | 1.9 | 1.4 | 2.6 | 2.3 | 47.7 | 72.8 | 27.2 | -11.6 | 45.7 | 0.9 | 1.2 | 347.7 |
| 4521 | 科研製薬 | prime | 76871M | 1.4 | -0.3 | -1.2 | 2.8 | 52.0 | 82.8 | -18.3 | -14.0 | 70.8 | 1.0 | 4.7 | 452.1 |
| 4539 | 日本ケミファ | standard | 33090M | 1.0 | 0.3 | 0.5 | 0.6 | 25.4 | 39.0 | 1.6 | -0.1 | 28.8 | 0.3 | 3.2 | 235.8 |
| 4502 | 武田薬品工業 | prime | 4505720M | -2.1 | 0.0 | 0.1 | -3.4 | 65.1 | 47.9 | -1.7 | 14.9 | - | 1.3 | 3.4 | 109.1 |
| 4587 | ペプチドリーム | prime | 18521M | -6.9 | -4.8 | -27.1 | -20.2 | 40.6 | 66.9 | -60.3 | -82.8 | - | 2.6 | - | 166.2 |
| 2160 | ジーエヌアイグループ | growth | 26840M | -9.8 | -5.0 | -12.9 | -26.6 | 74.5 | 60.1 | 13.7 | -11.0 | - | 3.3 | - | 424.6 |
| 4889 | レナサイエンス | growth | 69M | -12.0 | -7.5 | - | -439.5 | 93.7 | 94.5 | -48.3 | - | - | 4.8 | - | 1939.9 |
| 4893 | ノイルイミューン・バイオテック | growth | - | -18.4 | -14.2 | - | - | - | 97.8 | - | - | - | 1.5 | - | 5353.7 |
| 4565 | ネクセラファーマ | prime | 29615M | -19.3 | -6.3 | -28.6 | -42.3 | 72.3 | 45.3 | 2.7 | 9.3 | - | 1.9 | - | 254.1 |
| 4894 | クオリプス | growth | 212M | -20.0 | -16.1 | - | -485.3 | 61.4 | 91.6 | 21.2 | - | - | 10.2 | - | 1592.9 |
| 4891 | ティムス | growth | - | -21.2 | -22.8 | - | - | - | 92.1 | - | - | - | 1.8 | - | 1397.3 |
| 130A | Veritas In Silico | growth | 91M | -21.3 | -15.6 | - | -467.1 | - | 94.6 | -53.2 | 166.6 | - | 1.6 | - | 1846.3 |
| 206A | PRISM BioLab | growth | 677M | -26.9 | -20.1 | -114.3 | -123.1 | 39.8 | 87.6 | 121.6 | - | - | 2.2 | - | 821.1 |
| 4888 | ステラファーマ | growth | 323M | -27.7 | -14.7 | - | -241.5 | 86.3 | 54.1 | -66.4 | -108.3 | - | 6.0 | - | 1674.5 |
| 4584 | キッズウェル・バイオ | growth | 6590M | -28.1 | -2.9 | -2.1 | -6.3 | 26.5 | 26.4 | 29.7 | -16.8 | - | 4.9 | - | 271.7 |
| 4599 | ステムリム | growth | - | -28.7 | -23.5 | - | - | - | 78.0 | - | - | - | 1.8 | - | 8334.9 |
| 4892 | サイフューズ | growth | 231M | -29.7 | -15.9 | - | -330.7 | 49.3 | 62.3 | 324.3 | - | - | 2.4 | - | 454.3 |
| 4571 | NANOホールディングス | growth | 174M | -30.1 | -13.2 | - | -540.9 | 87.8 | 59.9 | 60.8 | - | - | 2.3 | - | 528.5 |
| 4591 | リボミック | growth | 3M | -38.9 | -29.7 | - | -38178.7 | - | 95.4 | 42.4 | - | - | 1.5 | - | 2167.5 |
| 4596 | 窪田製薬ホールディングス | growth | 21M | -42.2 | -34.5 | - | -3169.7 | -22.5 | 91.6 | -21.5 | - | - | 5.9 | - | 1251.2 |
| 4575 | キャンバス | growth | - | -44.4 | -26.7 | - | - | - | 95.4 | - | - | - | 5.0 | - | 2766.6 |
| 4586 | メドレックス | growth | 128M | -45.7 | -33.2 | - | -731.8 | 99.1 | 92.2 | -50.3 | - | - | 1.8 | - | 2361.7 |
| 4592 | サンバイオ | growth | - | -51.6 | -34.5 | - | - | - | 85.4 | - | - | - | 5.4 | - | 2899.1 |
| 190A | Chordia Therapeutics | growth | - | -54.2 | -51.5 | - | - | - | 90.8 | - | - | - | 1.9 | - | 1092.4 |
| 4884 | クリングルファーマ | growth | 72M | -54.4 | -49.8 | - | -1268.8 | - | 61.5 | -9.8 | - | - | 2.5 | - | 1879.8 |
| 4896 | ケイファーマ | growth | - | -56.4 | -23.2 | - | - | - | 43.1 | - | - | - | 7.4 | - | 2840.5 |
| 4882 | ペルセウスプロテオミクス | growth | 136M | -57.7 | -45.8 | - | -529.9 | 85.7 | 70.1 | 12.6 | - | - | 2.8 | - | 2458.5 |
| 4576 | デ・ウエスタン・セラピテクス研究所 | growth | 388M | -58.3 | -24.3 | -159.9 | -163.1 | 90.0 | 66.1 | -17.8 | -128.0 | - | 2.6 | - | 990.8 |
| 4597 | ソレイジア・ファーマ | growth | 429M | -60.2 | -34.4 | - | -204.2 | 48.3 | 81.7 | 35.8 | - | - | 4.4 | - | 605.8 |
| 4588 | オンコリスバイオファーマ | growth | 29M | -61.1 | -38.7 | - | -7209.6 | - | 87.6 | -9.0 | - | - | - | - | 954.8 |
| 4890 | 坪田ラボ | growth | 200M | -62.2 | -42.2 | - | -380.9 | 65.8 | 65.5 | -85.3 | - | - | 7.8 | - | 314.0 |
| 4593 | ヘリオス | growth | 104M | -63.8 | -49.5 | - | -2143.3 | -109.6 | 28.7 | -81.4 | - | - | 7.0 | - | 199.8 |
| 4583 | カイオム・バイオサイエンス | growth | 593M | -65.1 | -38.5 | -165.1 | -165.6 | 59.9 | 64.1 | -24.0 | -167.1 | - | 5.8 | - | 412.6 |
| 4564 | オンコセラピー・サイエンス | growth | 809M | -66.7 | -27.4 | -100.2 | -112.6 | 1.7 | 87.8 | 7.8 | -121.9 | - | 4.1 | - | 1359.0 |
| 4883 | モダリス | growth | - | -68.5 | -56.2 | - | - | - | 93.0 | - | - | - | 1.0 | - | 2145.6 |
| 4594 | ブライトパス・バイオ | growth | 0M | -80.3 | -38.6 | - | -1553513.1 | 64.3 | 90.1 | -92.6 | - | - | 3.4 | - | 1583.0 |
| 4881 | ファンペップ | growth | 0M | -96.1 | -80.1 | - | -608766.6 | - | 72.7 | -94.9 | - | - | 1.7 | - | 374.5 |
| 4572 | カルナバイオサイエンス | growth | 579M | -156.0 | - | - | -375.0 | 67.0 | 25.1 | -9.0 | - | - | - | - | 699.4 |
| 4582 | シンバイオ製薬 | growth | 1308M | -198.8 | - | - | -365.3 | 72.4 | 23.9 | -46.7 | - | - | 3.5 | - | 296.4 |
| 4563 | アンジェス | growth | 874M | - | - | - | -586.1 | 36.7 | 55.2 | 35.8 | - | - | 4.6 | - | 195.5 |
| 520A | ジェイファーマ | growth | - | - | -63.9 | - | - | - | 85.4 | - | - | - | 1.7 | - | 1257.1 |
| 4598 | Delta-Fly Pharma | growth | - | - | - | - | - | - | 12.6 | - | - | - | - | - | 97.8 |
| 4880 | セルソース | standard | 3711M | - | 2.2 | 4.5 | 0.3 | 56.2 | 84.0 | - | 8.9 | - | 1.1 | 1.5 | 1239.2 |
| 504A | イノバセル | growth | - | - | -76.5 | - | - | - | - | - | - | - | - | - | 1040.5 |